Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

405 results about "Bioactive molecules" patented technology

Bioactive molecules are substance that can be acted upon by a living organism or by an extract from a living organism. These molecules especially glycosaminoglycans(a polysaccharides) have therapeutic potential.

Stem cell exosome vesicles induced by traditional Chinese medicine functional components as well as preparation method and application of stem cell exosome vesicles

PendingCN120424865AMetabolism disorderCulture processBeta-cell FunctionIslet cells
The invention provides a stem cell exosome vesicle induced by traditional Chinese medicine functional components as well as a preparation method and application thereof, and belongs to the technical field of biological medicines. According to the preparation method of the stem cell exosome vesicle, traditional Chinese medicine functional components serve as an exosome inducer, stem cells can be induced to proliferate and secrete exosome with the enhanced function, the yield of the exosome can be increased, bioactive molecules can be loaded, and the bioavailability of the exosome in diabetes treatment is remarkably improved. The stem cell exosome vesicle disclosed by the invention can be applied to treatment of diabetes and complications thereof, not only can improve functions of islet cells, but also can treat chronic inflammation, microangiopathy and other metabolic diseases related to diabetes, and has a wide clinical application prospect.
Owner:北京圣美细胞生命科学工程研究院有限公司

Preparation method of pyrazolone amino-acid ester derivative

The invention discloses a preparation method of a pyrazolone amino-acid ester derivative. The pyrazolone amino-acid ester derivative is obtained through three-component cascade reaction by taking pyrazolone imine, a pentafluorophenylacetate derivative and alcohol as reactants and chiral isothiourea as a catalyst. According to the invention, challenges of competitive side reactions between a plurality of reaction substrates and intermediates and stereoselectivity control are overcome, the application range of the substrate combination of the existing system is broken through, and synthesis of a series of pyrazolone amino-acid ester derivatives is realized in a green and efficient manner. According to the method disclosed by the invention, substrate preassembly is not needed, transition metal catalysis is not needed, raw materials and the catalyst are cheap and easy to obtain, reaction conditions are mild, and the substrate application range is wide. In addition, the invention also provides a new way for introducing the medicine bioactive molecules into the synthesis of the pyrazolone amino-acid ester compound.
Owner:FUJIAN NORMAL UNIV

Electroporation buffer solution applied to exosome electroporation

The invention belongs to the technical field of biology, and provides an electroporation buffer solution applied to exosome electroporation, the pH value is 6.8-9.8, the osmotic pressure is 80-320 mosm, water is used as a solvent, and the electroporation buffer solution comprises the following components: 15-25% w / v of iodixanol, 1.035-1.265 mM of KH2PO4, 22.5-27.5 mM of KCl, 0.18-0.22 mM of EDTA-2Na and 18-22 mM of HEPES. The electroporation buffer solution provided by the invention can improve the loading efficiency of the load and reduce damage to an exosome membrane structure and internal bioactive molecules in an electroporation process. The electroporation buffer solution can effectively reduce aggregation and fusion phenomena of exosomes after electroporation, and improves the stability and integrity of the exosomes. The electroporation buffer solution provided by the invention can improve the application degree of the exosome as a targeting drug delivery system.
Owner:SHANDONG QILU CELL THERAPY ENG TECH CO LTD +1

Modified DDAH polypeptides and their use to extracorporeally treat a patient's blood to reduce levels of ADMA

ActiveUS12227779B2DiseaseMedicine
Modified DDAH polypeptides and their uses thereof are provided. Exemplary embodiments provide DDAH polypeptides which include one or more amino acid substitutions, additions, or deletions with natural or non-naturally encoded amino acids, and / or linkage to other biologically active molecules including other DDAH polypeptides, as well as PKEM. Additionally, use of said DDAH polypeptides for treatment of disease, such as heart failure or renal disease, is also provided.
Owner:THE TRUSTEES OF INDIANA UNIV

Multi-active targeting tumor nano-drug with multimode imaging function and immune activation effect and preparation method of multi-active targeting tumor nano-drug

The invention discloses a multi-active targeting tumor nano-drug with a multimode imaging function and an immune activation effect and a preparation method thereof, and belongs to the technical field of nano-drugs. The preparation method comprises the following steps: coupling inorganic metal-based nano particles / nano drugs with a multimode imaging function or / and targeting active organic biomolecules with specific functions and specific therapeutic drugs through a silane cross-linking agent or a combination of the silane cross-linking agent and a carbodiimide condensing agent; the active targeting type organic-inorganic composite nano-drug aggregate with a multi-mode imaging function and an immune activation effect is prepared. Wherein the inorganic component is a metal-based heterostructure nanoparticle with a multimode imaging function, and the organic component is a bioactive molecule or / and a specific therapeutic drug. The obtained nano-drug aggregate is stable in system, uniform and controllable in size and good in biocompatibility, and has specific targeting, such as specific targeting liver cancer cells.
Owner:UNIV OF SCI & TECH BEIJING

Antibody drug conjugate as well as preparation method and application thereof

The invention relates to an antibody drug conjugate which is shown in a formula (I) and contains two or more bioactive molecules with different action mechanisms, a preparation method of the antibody drug conjugate, and application of the antibody drug conjugate in prevention and / or treatment of diseases related to abnormal cell activity, including but not limited to prevention and / or treatment of tumor diseases. # imgabs0 #
Owner:MEDILINK THERAPEUTICS (SUZHOU) CO LTD

Small extracellular vesicles containing Klotho protein and / or mRNA as well as preparation method and application of small extracellular vesicles

The invention relates to a small extracellular vesicle containing Klotho protein and / or mRNA as well as a preparation method and application of the small extracellular vesicle. The preparation method of the small extracellular vesicle comprises the following steps: S1, constructing a recombinant expression vector containing a Klotho protein coding gene; s2, introducing the recombinant expression vector into recipient cells to obtain a receptor cell strain with stable expression of the Klotho gene; and S3, culturing the receptor cell strain, collecting a culture supernatant, and extracting the small extracellular vesicles from the culture supernatant. The small extracellular vesicles containing the Klotho protein and / or mRNA can regulate and control the expression of endogenous Klotho, the expression profile of bioactive molecules in the small extracellular vesicles is also changed, the small extracellular vesicles are rich in various kidney protective proteins, miRNA and other bioactive molecules, and the treatment effect on AKI and AD is remarkably enhanced.
Owner:THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIV

Aptamer APT-Cai for targeting myocardial cells and biomolecular transport carrier

The invention provides a nucleic acid aptamer and a screening method thereof, the aptamer is of an oligonucleotide DNA structure, the nucleotide sequence of the nucleic acid aptamer is the nucleotide sequence of any DNA fragment as shown in SEQ ID NO: 1-9, and the nucleic acid aptamer can specifically target cardiac muscle cells (CMs). According to the invention, a new strategy can be provided for clinical treatment of cardiovascular diseases, and meanwhile, bioactive molecules such as microRNA (miRNA), small interfering RNA (small interfering RNA, siRNA), lipidosome, microspheres, microcapsules and the like can be carried to be used as an intracellular drug delivery tool.
Owner:CHINA THREE GORGES UNIV +1

Composition containing rosemary exosome vesicles and application of composition in anti-inflammation

The invention relates to the technical field of food, medicine and health care products, and discloses a composition containing rosemary exosome vesicles and application of the composition in anti-inflammatory, the composition is formed by mixing plant cell-derived exosome vesicles and functional active ingredients, the composition comprises the following components in percentage by mass: 45-55% of rosemary exosome and 45-55% of turmeric exosome; the preparation method of the composition containing the rosemary exosome vesicles comprises the following steps: S1, taking a certain amount of fresh rosemary and turmeric plants, removing root hairs and impurities, washing the fresh plants with domestic drinking water, washing the fresh plants with purified water for three times, and finally washing the fresh plants with ultrapure water for three times for 3-5 minutes each time; the product can carry various bioactive molecules, transfer cell signals in a transboundary manner, participate in anti-inflammation, inhibit tumor cell proliferation and promote normal tissue repair, has an anti-inflammatory effect, inhibits release of inflammatory factors, improves the immune function of a body and adjusts the immune balance state, and can play a role in neovascularization diseases of the body.
Owner:HANGZHOU YIKEJIAN BIOTECHNOLOGY CO LTD

T Cell Modification and Use Thereof

This invention relates to modified T cells that inducibly express a bioactive molecule, such as IL-7, and constitutively expresses an antigen receptor, such as a T cell receptor or chimeric antigen receptor that binds to a tumour antigen. The modified T cells may comprise a nucleic acid construct that comprises a first nucleotide sequence encoding the bioactive molecule, a second nucleotide sequence encoding the antigen receptor; an inducible promoter operably linked to the first nucleotide sequence and a constitutive promoter operably linked to the second nucleotide. Nucleic acid constructs and vectors are provided, as well as T cells comprising such constructs and vectors and therapeutic methods and uses thereof.
Owner:ADAPTIMMUNE

Nanomaterial delivery carriers and methods of use thereof

The self-assembled nano material comprises a Janus-based nano tube, wherein the Janus-based nano tube comprises at least one compound represented by a formula I to a formula XII, or a pharmaceutically acceptable salt of the compound. Also described are compositions comprising the Janus-based nanotubes, comprising a biologically active molecule covalently or non-covalently attached to the self-assembled nanomaterial.
Owner:UNIV OF CONNECTICUT

Synthesis method of novel benzosuberone compound

The invention discloses a synthesis method of a novel benzosuberone compound, and belongs to the field of organic synthesis. The preparation method comprises the following steps: uniformly stirring methyltriphenylphosphonium bromide in a solvent at room temperature, dropwise adding an n-hexane solution of n-butyllithium in an ice-water bath, stirring a reaction system at room temperature for 30-40 minutes after dropwise adding is completed, then adding an initial raw material phenanthrenequinone 1 in the ice-water bath, transferring the reaction system to 40 DEG C for reaction, and after the reaction is monitored to be complete by a TLC (Thin Layer Chromatography) dot plate, filtering, washing and drying to obtain the phenanthrenequinone 1. And pouring the reaction liquid into a silica gel chromatographic column, and simply filtering by using dichloromethane as an eluent to remove salt and phosphine oxide. And performing rotary evaporation to remove the organic solvent to obtain a crude product, and separating and purifying to obtain a target product 2. The method is short in reaction time and low in reaction cost, provides a practical method for obtaining the seven-membered rigid ring skeleton, and has potential value for synthesis of natural products and bioactive molecules.
Owner:UNIV OF SCI & TECH OF CHINA

Injectable hydrogel capable of releasing exosome in microenvironment responsiveness and preparation method and application of injectable hydrogel

The invention belongs to the technical field of hydrogel, and particularly relates to injectable hydrogel capable of releasing exosome in a microenvironment responsive mode and a preparation method and application thereof.The injectable hydrogel takes sodium alginate and gelatin as main chains and is combined with exosome, and the system comprises a double-network structure formed by boric acid ester bonds and Schiff base bonds. A boric acid ester bond and a Schiff base bond react to a main chain of biomacromolecule gelatin and sodium alginate, a bioactive molecule exosome is combined, a microenvironment responsive injectable hydrogel combination combined with the exosome is constructed, and at the early stage of spinal cord injury, through the interaction of the boric acid ester bond and active oxygen in a microenvironment, the injectable hydrogel combination can be used for treating spinal cord injury. Meanwhile, active oxygen removal and exosome release are achieved, the microenvironment is purified in time, a beneficial support space is provided for nerve growth by utilizing retention of a Schiff base bond network in the SC I chronic stage, the combination is beneficial to movement and recovery of bladder functions, and clinical application is more facilitated through injectability of the combination.
Owner:BINZHOU MEDICAL COLLEGE

Stability-enhanced alginic acid-keratin-based double-coated nanoparticles as well as preparation method and application thereof

The invention discloses a preparation method of stability-enhanced alginic acid-keratin-based double-coated nanoparticles. The preparation method comprises the following steps: carrying out controllable enzymolysis, enzyme deactivation, centrifugation and freeze-drying on keratin to obtain keratin nanoparticles formed by self-assembly; dispersing the keratin nanoparticles in an acidic buffer solution to carry out structure development, adding bioactive molecules, and adjusting the pH to be neutral to recombine and close the keratin nanoparticle structure to obtain a keratin nanoparticle solution loaded with the bioactive molecules; the preparation method comprises the following steps: taking keratin as a template, dispersing the keratin into a sodium alginate solution, dropwise adding into a calcium chloride solution, cross-linking to form a calcium alginate shell, dialyzing or centrifuging to remove free bioactive molecules, and freeze-drying to obtain the bioactive molecule loaded alginic acid-keratin-based double-coated nanoparticles. The invention also discloses double-coated nanoparticles and application thereof, through controllable enzymolysis and pH regulation and control, the self-assembly and bioactive molecule encapsulation of the keratin nanoparticles are improved, and the double-coated nanoparticles with regular shape, good dispersibility, good redissolvability and good environmental stability are formed.
Owner:INST OF AGRO FOOD SCI & TECH CHINESE ACADEMY OF AGRI SCI

Multifunctional cyclic peptide and application thereof

The invention discloses a multifunctional cyclic peptide, and the structure of the multifunctional cyclic peptide is an end-to-end cyclization structure of tryptophan, leucine, lysine, arginine, tryptophan, leucine, arginine, lysine, leucine, tyrosine, lysine, phenylalanine, glycine and glycine. The multifunctional cyclic peptide has the advantages of the cyclic peptide, can be used as a novel bioactive molecule integrating antibacterial, anti-inflammatory and osteogenesis / tooth promoting functions, can meet various clinical requirements, and has a wide application prospect.
Owner:WEIFANG MEDICAL UNIV

Synthetic method of phenanthridone compound based on visible light catalysis

The invention relates to the technical field of organic catalysis, in particular to a synthesis method of a phenanthridone compound based on visible light catalysis, which comprises the following steps: (1) taking an N-aryl o-iodobenzamide derivative as a raw material, potassium polysulfide as a photocatalyst and potassium tert-butoxide as alkali, adding toluene into a glove box, and dissolving to obtain a reaction mixed solution; (2) reacting the reaction liquid at room temperature under the irradiation of visible light; and (3) after the reaction is finished, separating and purifying to obtain the product phenanthridone compound. The phenanthridone compound synthesized by the invention widely exists in natural products and drug molecules, is an important constituent unit in natural alkaloids and bioactive molecules, and has unique pharmacological and biological activities. Therefore, the synthesized compound has a wide application prospect in the fields of biological medicines and the like.
Owner:ANHUI POLYTECHNIC UNIV

Magnesium alloy surface bionic endothelial cell induction coating and preparation method thereof

The invention discloses a magnesium alloy surface bionic endothelial cell induction coating and a preparation method thereof, and relates to the technical field of biomedical materials.The preparation method comprises the steps that raw materials are prepared, an oxidation film is formed on the magnesium alloy surface, a monomolecular film is formed on the surface of the oxidation film, and the bionic endothelial cell induction coating is formed on the magnesium alloy surface through a dip-coating method; according to the preparation method, a uniform and compact oxide layer is formed on the surface of the magnesium alloy metal sheet by adopting an alkali heat method so as to improve the corrosion resistance of the magnesium alloy metal sheet, and then a uniform and compact monomolecular film is formed on the oxide layer on the surface of the magnesium alloy metal sheet by adopting a thermal organic film method so as to provide additional protection, so that the corrosion resistance and the biocompatibility of the magnesium alloy metal sheet are further enhanced; and finally, preparing a composite bionic solution from bioactive molecules, inorganic minerals, polylactic acid, polyhydroxyalkanoate, dichloromethane, acetone and water as raw materials, and taking the composite bionic solution as a bionic endothelial cell induction coating to endow the coating with good biodegradability and biocompatibility.
Owner:ZHONGYUAN ENGINEERING COLLEGE

Spiro butane indolone derivative as well as preparation method and application thereof

The invention provides a spiro butane indolone derivative as well as a preparation method and application thereof, and belongs to the technical field of organic chemical synthesis. The series cyclization coupling reaction of the N-iodo aryl dicyclobutyl amide compound and the vinyl pyridine compound is realized by utilizing a photocatalytic system, and the method is used for constructing the spiro butane indolone derivative containing the pyridine structure. The spirobutane indolone derivative synthesized by the invention has an inhibition effect on H1975 human lung adenocarcinoma cells; the preparation method provided by the invention is mild in condition and simple and convenient to operate, has economical steps, provides a convenient synthesis way for the complex bioactive molecules, and has a good application prospect.
Owner:GUANGDONG MEDICAL UNIV

Novel skin-permeable peptide, composition including the same for skin and mucous membrane, and use thereof

A skin-permeable peptide, a derivative thereof, or a fragment thereof of the present disclosure effectively delivers skin bioactive molecules deep into the skin tissues through assembly or fusion methods, thereby providing outstanding skin permeability as well as excellent skin residual effect of bioactive materials to maximize bioactive efficacy. Accordingly, the skin-permeable peptide, derivative thereof, or fragment thereof may be widely used as an active ingredient of a pharmaceutical composition for external use and a functional cosmetic composition that target skin tissues including mucous membranes.
Owner:CELLICON LAB INC

Nano dressing as well as preparation method and application thereof

The invention discloses a nano dressing and a preparation method and application thereof, the nano dressing comprises recombinant FN polypeptide, and the recombinant FN polypeptide has good biocompatibility and biological activity, small molecular weight and stable physicochemical properties. According to the invention, the recombinant FN polypeptide is combined with chitosan to construct protein nano chitosan particles loaded with the recombinant FN polypeptide, and the nano dressing is prepared. The nano dressing is verified by animal full-thickness wound experiments, and the experimental result shows that the nano dressing has the capabilities of accelerating angiogenesis, reducing inflammatory response and promoting wound healing.
Owner:AMBOWWAY BIOTECHNOLOGY (XIAMEN) CO LTD

T cell modification and use thereof

This invention relates to modified T cells that inducibly express a bioactive molecule, such as IL-7, and constitutively expresses an antigen receptor, such as a T cell receptor or chimeric antigen receptor that binds to a tumour antigen. The modified T cells may comprise a nucleic acid construct that comprises a first nucleotide sequence encoding the bioactive molecule, a second nucleotide sequence encoding the antigen receptor; an inducible promoter operably linked to the first nucleotide sequence and a constitutive promoter operably linked to the second nucleotide. Nucleic acid constructs and vectors are provided, as well as T cells comprising such constructs and vectors and therapeutic methods and uses thereof.
Owner:ADAPTIMMUNE

IL27RAlpha binding molecules and methods of use

The present disclosure relates to biologically active molecules comprising a single domain antibody (sdAb) that specifically binds to the extracellular domain of human IL27Rα, compositions comprising such antibodies, and methods of use thereof.
Owner:SYNTHEKINE INC

Membrane-wrapped organelle-like system for directionally assembling membrane protein

The invention provides a membrane-wrapped organelle-like system for directionally assembling membrane protein, which comprises a molecular framework and a closed lipid bilayer membrane wrapping the outer side of the molecular framework, the molecular framework is loaded with load molecules, the molecular framework directionally recombines the lipid bilayer membrane through a transmembrane region of the membrane protein, and the lipid bilayer membrane is loaded with the load molecules. The lipid bilayer membrane provides a barrier and protection for a molecular framework and loaded molecules, and the lipid bilayer membrane is provided with directional recognition molecules. According to the invention, a molecular framework wrapped by a lipid bilayer membrane is utilized, and a novel technology capable of simulating lipid vesicles of an organelle membrane framework is adopted, so that a brand-new directional delivery function on specific cells or specific organelles in the specific cells can be endowed. And oriented assembly of a membrane protein compound and effective loading of bioactive molecules are realized by using a process of chemically recombining the lipid bilayer membrane.
Owner:崂山国家实验室

Compositions and methods of isolating policosanol and sterols

PCT designated stage expiredWO2025012466A3Hydroxy compound separation/purificationDyslipidemiaFatty acid
The present disclosure provides compositions and methods of recovering a policosanol or a sterol from a mixture comprising one or more fatty alcohols, aldehydes, fatty acids, and / or sterols. The mixture may be, for example, a lipid extract obtained from industrial fermentation processes (e.g., filter cake, distillate residue). The policosanol and / or sterol fraction recovered may be enriched in certain fatty alcohols (e.g., 1-octacosanol, 1-triacontanol, and / or 1-dotriacontanol), or enriched in certain sterols (e.g., ergosterol, campesterol, stigmasterol, and / or β-sitosterol). These bioactive molecules may be useful in the treatment or prevention of various metabolic conditions (e.g., obesity, dyslipidemia, cardiovascular conditions, and other chronic metabolic diseases).
Owner:AMYRIS BIO PROD PORTUGAL UNIPESSOAL LDA +1

T cell activation responsive constructs for enhanced car-t cell therapy

The present disclosure generally relates to genetic circuits including response elements engineered from the NR4A1 that augment chimeric antigen receptor activation with the delivery of a bioactive molecule. Particularly, the disclosure provides nucleic acid constructs including response elements operably linked to a nucleic acid sequence of interest such that are responsive to activation of CAR-T cells. The disclosure also relates to vectors and cells including the genetic circuits and the nucleic acid constructs. Also provided are methods of inducing an immune response, methods of treatment of subjects, and methods for delivering a bioactive molecule by an activated T cell having a chimeric antigen receptor and the response element constructs of the disclosure.
Owner:RGT UNIV OF CALIFORNIA

Bamboo shoot insoluble dietary fiber, pea protein and alginate ternary composite hydrogel as well as preparation method and application thereof

The invention relates to the technical field of food gel, in particular to bamboo shoot insoluble dietary fiber, pea protein and alginate ternary composite hydrogel as well as a preparation method and application thereof. By adjusting the pH value of a reaction system (a pH driving method) and introducing the insoluble dietary fibers into the binary gel, the use of a chemical cross-linking agent is reduced, and the property of the hydrogel is improved. The finally obtained hydrogel has the following advantages: the structure becomes more compact and uniform, and the deformability is also reduced; the mechanical strength is good, and possibility is provided for encapsulation of bioactive molecules; higher thermal stability is shown; the crystallinity is higher, and the mechanical strength and the functional stability are improved; the water retention capability of a gel network in the structure can be enhanced, and the porous structure is beneficial to stabilizing water molecules.
Owner:GUIZHOU UNIV

Derivatives of 5-hydroxylated polymethoxyflavones with enhanced bioavailability for oral delivery and compositions thereof

We are disclosing derivatives of 5-hydroxylated polymethoxyflavones. The derivatives offer enhanced oral bioavailability and improved intestinal permeability. The derivatives of the invention release the biologically active 5-hydroxylated polymethoxyflavones that are activated by chemical or enzymatic processes in the GI Tract. The derivatives are constructed as bioreversible prodrugs containing the bioactive molecules covalently linked with lipids like fatty acids, glycerides or phospholipids. The derivatives are useful against inflammatory conditions and aging. Formulations including the derivatives are also disclosed.
Owner:DEEPSENSE BIOTECHNOLOGIES INC

Blood filtering membrane preparation device and method

The invention discloses a blood filtering membrane preparation device and method, and belongs to the technical field of blood filtering membrane preparation. The method comprises the steps that materials are prepared, a membrane material is polyethersulfone, a solvent is a mixed solvent and specifically comprises N-methyl pyrrolidone (NMP) and gamma-butyrolactone, additives comprise a pore-forming agent, an anticoagulant and bioactive molecules, and the bioactive molecules are heparin. A spinning solution is uniformly dispersed through the ultrasonic dispersion instrument and the magnetic stirrer, the agglomeration state of a membrane material and an additive in a solvent is effectively broken through through the strong vibration and cavitation effect of the ultrasonic dispersion instrument, and full contact and mixing of all components are promoted; therefore, the uniformity of a mixed solution before spinning is remarkably improved, a blood filtering film forming structure is more compact, pore distribution is more uniform, the spinning solution is stirred in cooperation with a magnetic stirrer, agglomeration of particles in the spinning solution is reduced, and the uniformity and stability of the spinning solution can be more effectively improved.
Owner:DALTON BIOTECHNOLOGY (SHENZHEN) CO LTD